Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell

被引:57
作者
Liao, Yun-fei [1 ]
Feng, Yong [2 ]
Chen, Lu-Lu [1 ]
Zeng, Tian-shu [1 ]
Yu, Fan [1 ]
Hu, Li-jun [3 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Endocrinol, Wuhan 430074, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Dept Orthoped, Wuhan 430074, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Dept Ultrasound Diag, Wuhan 430074, Peoples R China
关键词
Coronary heart disease; Risk equivalents; Type; 2; diabetes; Peripheral arterial disease; Carotid artery disease; Endothelial function; Endothelial progenitor cell; LONG-TERM SURVIVAL; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; IMPACT; MORTALITY; NUMBER; MARKER;
D O I
10.1016/j.jdiacomp.2013.09.009
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Aims: Peripheral Arterial Disease (PAD), Carotid Artery Disease (CAD), and Type 2 Diabetes Mellitus (DM) were considered as "Coronary Heart Disease (CHD) risk equivalents". Vascular endothelial dysfunction was recognized as an early event in the development of atherosclerosis. Involved in neovasculogenesis and maintenance of vascular homeostasis, endothelial progenitor cell (EPC) has been considered as a biological marker of cardiovascular disease. The purpose of this study was to assess the CHD risk equivalents concept by investigating the endothelial function and circulating EPC number in patients with CHD, PAD, CAD' and T2DM. Methods: There were four groups in the study: CHD (n = 19), AD [PAD and CAD (n = 17)], DM (n = 21) and healthy controls (HC, n = 20). PAD and CAD were assessed by ultrasonography. Coronal artery angiography was used to identify CHD. The diagnosis of T2DM was based on oral glucose tolerance test and medical history. Vascular endothelial function was assessed by flow-mediated brachial artery dilatation (FMD). Circulating EPC was quantified by flow cytometry. Results: The circulating EPC numbers in four groups were CHD, 973 +/- 96; AD, 1048 +/- 97; T2DM, 1210 +/- 125; HC, 1649 +/- 112 cells/ml. There were no significant differences in circulating EPC numbers between CHD and AD groups (P > 0.05). Compared with CHD or AD group, T2DM group was associated with a slight increase in circulating EPC numbers (P < 0.05). The results of FMD were almost similar to the circulating EPC numbers(CHD, 4.06 +/- 0.54; AD, 3.90 +/- 0.48; DM, 3.85 +/- 0.57; HC, 5.52 +/- 0.67%)except that there was no significant difference among the CHD, AD and T2DM groups (P > 0.05). Age, glycosylated hemoglobin, low density lipoprotein cholesterol, systolic blood pressure, body mass index (BMI) and medical history were the independent risk factors of circulating EPC number in all the patients (P < 0.05). Age, total cholesterol, BMI and medical history were the independent risk factors of FMD in all of the patients (P < 0.05). Conclusions: The results of this study supported the equivalents hypothesis and revealed that "CHD risk equivalents" were characterized by the consistent physiological changes of blood vessels in angiogenesis, repairing ability and endothelial function. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:214 / 218
页数:5
相关论文
共 24 条
[1]
Endothelinrole in vascular disease [J].
Abraham, D. ;
Dashwood, M. .
RHEUMATOLOGY, 2008, 47 :V23-V24
[2]
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[3]
Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients [J].
Chen, Lu-lu ;
Liao, Yun-fei ;
Zeng, Tian-shu ;
Yu, Fan ;
Li, Hui-qing ;
Feng, Yong .
ENDOCRINE, 2010, 38 (02) :266-275
[4]
Chen Lu-Lu, 2009, Zhonghua Yi Xue Za Zhi, V89, P1234
[5]
The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men [J].
Cho, E ;
Rimm, EB ;
Stampfer, MJ ;
Willett, WC ;
Hu, FB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) :954-960
[6]
Surrogate markers for cardiovascular disease functional markers [J].
Cohn, JN ;
Quyyumi, AA ;
Hollenberg, NK ;
Jamerson, KA .
CIRCULATION, 2004, 109 (25) :31-46
[7]
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy [J].
Fadini, Gian Paolo ;
Sartore, Saverio ;
Albiero, Mattia ;
Baesso, Ilenia ;
Murphy, Ellen ;
Menegolo, Mirko ;
Grego, Franco ;
de Kreutzenberg, Saula Vigili ;
Tiengo, Antonio ;
Agostini, Carlo ;
Avogaro, Angelo .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (09) :2140-2146
[8]
Endothelial progenitor cells and the diabetic paradox [J].
Fadini, GP ;
Sartore, S ;
Baesso, I ;
Lenzi, M ;
Agostini, C ;
Tiengo, A ;
Avogaro, A .
DIABETES CARE, 2006, 29 (03) :714-716
[9]
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[10]
Kawamoto A, 2001, CIRCULATION, V103, P634